Skip to Main Content
Welcome to theĀ Scientist.comĀ Marketplace

Go to Main Navigation

BP9289c

ERC1 Antibody (Center) Blocking Peptide

Abcepta

DETAILS

  • Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
  • Gene Id: 23085
  • Category: Peptides; Blocking Peptides
  • Subtitle: Synthetic peptide
  • Gene Name: ERC1
  • Other Names: ELKS/Rab6-interacting/CAST family member 1, ERC-1, Rab6-interacting protein 2, ERC1, ELKS, KIAA1081, RAB6IP2
  • Availability: 2 weeks
  • Bio Background: Regulatory subunit of the IKK complex. Probably recruits IkappaBalpha/NFKBIA to the complex. May be involved in the organization of the cytomatrix at the nerve terminals active zone (CAZ) which regulates neurotransmitter release. May be involved in vesicle trafficking at the CAZ. May be involved in Rab-6 regulated endosomes to Golgi transport. The protein is a member of a family of RIM-binding proteins. RIMs are active zone proteins that regulate neurotransmitter release. This gene has been found fused to the receptor-type tyrosine kinase gene RET by gene rearrangement due to the translocation t(10;12)(q11;p13). Five transcript variants encoding different isoforms have been found for this gene.
  • Primary Accession: Q8IUD2
  • Targetspecificity: The synthetic peptide sequence used to generate the antibody AP9289c was selected from the Center region of human ERC1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.